Trial Profile
Prospective cohort study for safety and efficacy of low dose nab-paclitaxel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 10 Nov 2017 Status changed from recruiting to completed.
- 04 Mar 2014 New trial record